Showing results (2321-2330 of 2,473) with videos related to
Sort By:
Pageof 248
Cancer Treatment Reviews|February 13, 2022
The association between guideline adherence, age and overall survival among women with non-metastatic breast cancer: A systematic reviewKatie Miller, Irene A Kreis, Melissa R Gannon, et al.Cancer Treatment Reviews|February 17, 2022
Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysisAlberto Martini, Daniele Raggi, Giuseppe Fallara, et al.Cancer Treatment Reviews|September 26, 2021
The role of the tumor primary chemosensitivity relative to the success of the medical-surgical management in patients with advanced ovarian carcinomasBenoit You, Gilles Freyer, Antonio Gonzalez-Martin, et al.Cancer Treatment Reviews|February 3, 2022
Chemotherapy in pancreatic ductal adenocarcinoma: When cytoreduction is the aim. A systematic review and meta-analysisMonica I Meneses-Medina, Lorenzo Gervaso, Chiara A Cella, et al.Cancer Treatment Reviews|March 18, 2022
First-line immune checkpoint inhibitors in advanced or metastatic renal cell carcinoma with sarcomatoid featuresMário Fontes-Sousa, Emiliano CalvoCancer Treatment Reviews|April 12, 2022
Integration of immunotherapy into treatment of cervical cancer: Recent data and ongoing trialsBradley J Monk, Takayuki Enomoto, W Martin Kast, et al.Cancer Treatment Reviews|September 3, 2018
Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinomaMichael B Atkins, Nizar M TannirCancer Treatment Reviews|August 21, 2018
Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapyPaul Sargos, Brian C Baumann, Libni Eapen, et al.Cancer Treatment Reviews|June 26, 2018
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtypeL Gerratana, D Basile, G Buono, et al.Cancer Treatment Reviews|May 21, 2019
Improving attribution of adverse events in oncology clinical trialsGoldy C George, Pedro C Barata, Alicyn Campbell, et al.Pageof 248